VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PACSPACS Group, Inc.
$41.89$6.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksPACSCash Flow

PACS Group, Inc. (PACS) Cash Flow Statement

4Y historyFree accessUpdated daily

Free cash flow generation remains erratic, evidenced by a swing from a negative 8.7% margin in 2025Q4 to a positive 15.1% margin in 2026Q1.

PACS Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22
Cash from Operations490.31M404.22M367.34M63.7M92.61M
Operating CF Margin %-7.64%8.98%2.05%3.82%
Operating CF Growth %0.95%10.04%476.7%-31.22%-
Net Income243.77M055.76M112.87M150.5M
Depreciation & Amortization61.03M040.81M25.63M22.31M
Stock-Based Compensation41.87M0115.54M00
Deferred Taxes-10.61M0-44.48M-9.92M-1.92M
Other Non-Cash Items67.8M331.51M41.5M29.77M16.02M
Working Capital Changes86.45M72.71M158.22M-94.66M-94.29M
Change in Receivables8.48M14.43M-116.45M-179.94M-114.62M
Change in Inventory00000
Change in Payables-19.68M14.86M33.4M33.37M32.81M
Cash from Investing-374.97M-264.02M-442.68M-172.79M-75.32M
Capital Expenditures-253.27M0-66.47M-45.78M-78.24M
CapEx % of Revenue4.66%1.99%1.63%1.47%3.23%
Acquisitions0----
Investments107.32M87.19M91.38M55.96M48.31M
Other Investing5.04M-264.02M-4M750K2.92M
Cash from Financing-132.24M-68.99M117.48M129.59M12.35M
Debt Issued (Net)0----
Equity Issued (Net)00509.44M00
Dividends Paid00-33.72M-80.39M-60.28M
Share Repurchases00000
Other Financing-19.64M-8.77M-33.09M587K3.25M
Net Change in Cash-16.89M71.21M42.14M20.5M29.64M
Free Cash Flow237.05M298.82M300.88M17.91M14.38M
FCF Margin %4.36%5.65%7.36%0.58%0.59%
FCF Growth %-14.35%-0.68%1579.46%24.59%-
FCF per Share1.461.912.030.120.10
FCF Conversion (FCF/Net Income)0.97x2.11x6.59x0.56x0.62x
Interest Paid32.42M40.51M48.25M50.56M25.91M
Taxes Paid83.69M84.05M107.83M60.01M42.55M

Key Metrics

Growth RegimeExpanding
ProfitabilityStrained
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Regulatory reimbursement policy shifts

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality and Cash Divergence

As reported in recent financial statements, PACS Group exhibits significant volatility in its cash conversion, with the OCF/NI ratio swinging from a negative 0.06 in 2025Q4 to a high of 5.28 in 2025Q1, suggesting that reported net income is a poor proxy for actual cash generation.

The wide variance between net income and operating cash flow indicates that non-cash items and working capital fluctuations heavily distort the company's bottom-line performance. Investors should monitor whether this inconsistency stems from the timing of government reimbursements or the aggressive accounting treatment of newly acquired facility assets.

Inconsistent Free Cash Flow Generation

Based on the provided quarterly data, PACS Group's free cash flow trajectory remains highly erratic, with margins oscillating between a negative 8.7% in 2025Q4 and a positive 15.1% in 2026Q1, reflecting the capital-intensive nature of its rapid expansion strategy within the post-acute care sector.

The inability to maintain consistent positive free cash flow suggests that the company's growth model is highly sensitive to the timing of capital expenditures and facility-level operational performance. This instability warrants caution, as the company appears to rely on periodic cash inflows to offset the heavy costs associated with its acquisition-led growth.

Capital Intensity and Asset Maintenance

According to the company's cash flow filings, capital expenditures have spiked significantly, reaching $114.3 million in 2025Q4, which represents a substantial 8.4% of revenue and indicates a heavy reinvestment requirement to maintain the clinical standards of its expanding portfolio of skilled nursing facilities.

The high capital intensity suggests that PACS must continuously invest in its physical infrastructure to remain competitive and compliant with regulatory standards. Analysts should investigate whether these expenditures are primarily for maintenance or if they represent necessary upgrades to integrate newly acquired facilities into the company's decentralized operating model.

Working Capital Volatility and Liquidity

As evidenced by the quarterly cash flow data, working capital changes have been a major source of volatility, with a $118.1 million inflow in 2026Q1 contrasting sharply with a $119.8 million outflow in 2025Q4, highlighting the company's susceptibility to shifts in billing cycles and collection timing.

The dramatic swings in working capital suggest that the company's liquidity is heavily dependent on the efficiency of its accounts receivable processes, particularly regarding Medicaid and Medicare reimbursements. Such fluctuations may indicate underlying challenges in managing the cash conversion cycle across a geographically dispersed and rapidly growing facility network.

PACS — Frequently Asked Questions

Quick answers to the most common questions about buying PACS stock.

How much cash does PACS Group, Inc. (PACS) generate from operations?

PACS Group, Inc. (PACS) generated $404.2M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is PACS Group, Inc.'s free cash flow?

PACS Group, Inc. (PACS) generated $298.8M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is PACS Group, Inc.'s capital expenditure (CapEx)?

PACS Group, Inc. (PACS) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.